Benzinga | Oct 14, 2020 04:08PM EDT

Nurix Therapeutics Q3 EPS $(0.59) Misses $(0.41) Estimate, Sales $4.08M Miss $6.34M Estimate

Nurix Therapeutics (NASDAQ:NRIX) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate of $(0.41) by 43.9 percent. This is a 10.61 percent increase over losses of $(0.66) per share from the same period last year. The company reported quarterly sales of $4.08 million which missed the analyst consensus estimate of $6.34 million by 35.57 percent. This is a 61.39 percent decrease over sales of $10.58 million the same period last year.